Biochemistry, Genetics and Molecular Biology
Pharmacokinetics
50%
P53
50%
Pharmacodynamics
50%
Circulating Tumor DNA
50%
Dynamics
50%
Next Generation Sequencing
50%
Exon
50%
Creatinine
50%
Clinical Study
50%
Protocol Compliance
50%
RNA Sequence
50%
Cyclin-Dependent Kinase 4
41%
Cell Cycle
25%
Phosphatidylinositol-4,5-bisphosphate 3-Kinase
25%
Enzyme Active Site
25%
Gene Frequency
25%
Alpha Chain
25%
Wild Type
25%
Cancer Cell
16%
Biological Functions
16%
Tumor Progression
16%
Anticancer
16%
Blood Level
11%
Glomerulus Filtration
11%
Cystatin C
11%
Medline
10%
Embase
10%
Somatic Mutation
10%
Copy-Number Variation
10%
Methylation
10%
Secretion (Process)
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
79%
Ribociclib
50%
Abemaciclib
50%
Protein P53
50%
Palbociclib
50%
Metastatic Breast Cancer
50%
Circulating Tumor DNA
50%
Clinical Study
50%
Acute Kidney Failure
50%
Creatinine
50%
Pharmacodynamics
33%
Prematurity
33%
Cyclin Dependent Kinase 4
33%
Neoplasm
26%
Malignant Neoplasm
16%
Clinical Pharmacokinetics
16%
Anticarcinogen
16%
Tumor Growth
16%
Growth Disorder
16%
Pharmacokinetics
16%
Diseases
16%
Cystatin C
11%
DNA Fragment
10%
Kidney Injury
5%
Medicine and Dentistry
Cell-Free DNA
100%
Metastatic Breast Cancer
50%
Systematic Review
50%
Circulating Tumor DNA
50%
Treatment Response
30%
Exon
25%
Next Generation Sequencing
25%
Breast Cancer
22%
Liquid Biopsy
12%
Blood Donor
12%
Solid Malignant Neoplasm
12%
Cell Line
12%
Enzyme Active Site
12%
Alpha Chain
12%
Diagnostic Accuracy
12%
Molecular Diagnostics
12%
Targeted Therapy
12%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
12%
Gene Frequency
12%
Neoplasm
10%
Somatic Mutation
10%
Methylation
10%
Clinical Assessment
10%
Copy Number Variation
10%
Systemic Therapy
10%
